Evaluation of the Contribution of Low-pressure Intra-abdominal Insufflation for Laparoscopic Colic Resection

NCT ID: NCT04112654

Last Updated: 2024-04-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

128 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-06-29

Study Completion Date

2023-10-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The laparoscopic surgery requires gas insufflation in the peritoneal cavity and the operator chooses the intraabdominal insufflation pressure. In general, during a conventional laparoscopy, this pressure is 12 to 15 mmHg. The reduction of the intra-abdominal pressure minimizes the parietal trauma due to the insufflation and could lead to a reduction of the postoperative pains and could allow an earlier recovery. In this study, the investigator propose to evaluate the benefits of a low pressure insufflation (6-8 mmHg) with pressure-controlled insufflator in patients with a mild or malignant colon pathology requiring surgical colic resection. The main objective of the study is to demonstrate that the laparoscopic colic resection at low pressure reduces the theoretical hospital stay of one day compared to the conventional laparoscopy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colonic Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Conventional laparoscopy

Laparoscopy realized at the conventional pressure (12-15 mmHg) using conventional insufflator.

Group Type ACTIVE_COMPARATOR

Conventional pressure laparoscopy

Intervention Type PROCEDURE

Conventional pressure laparoscopy using conventional insufflator AirSeal®

Low pressure laparoscopy

Laparoscopy realized at low pressure (6-8mmHg) using pressure-controlled insufflator AirSeal®

Group Type EXPERIMENTAL

Low pressure laparoscopy

Intervention Type PROCEDURE

Low pressure laparoscopy using pressure-controlled insufflator AirSeal®

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Conventional pressure laparoscopy

Conventional pressure laparoscopy using conventional insufflator AirSeal®

Intervention Type PROCEDURE

Low pressure laparoscopy

Low pressure laparoscopy using pressure-controlled insufflator AirSeal®

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Colic lesion justifying surgical resection by segmental colectomy,
* Surgery proposed by laparoscopy,
* Body mass index (BMI) ≤30 kg/m2,
* Written informed consent signed by the patient,
* Patient affiliated to the national French statutory healthcare insurance, system or beneficiary of this regimen.

Exclusion Criteria

* Probable realization of a stoma during the procedure,
* Robot-assisted approach,
* Contraindication to laparoscopic surgery,
* Pregnant or likely to be pregnant,
* Patient deprived of liberty or placed under the authority of a tutor,
* Patient considered geographically socially or psychologically unable to comply with the study procedure and the medical follow-up.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institut Paoli-Calmettes

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Cecile DE CHAISEMARTIN, MD

Role: PRINCIPAL_INVESTIGATOR

Institut Paoli-Calmettes

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Institut Paoli Calmettes

Marseille, Bouches Du Rhone, France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

LOPRECOL-IPC 2017-02

Identifier Type: OTHER

Identifier Source: secondary_id

LOPRECOL-IPC 2017-02

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Gut Oxygenation and Laparoscopy
NCT01040013 COMPLETED PHASE2